Hexagon Capital Partners’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-67
Closed -$2.69K 1309
2025
Q1
$2.69K Sell
67
-24
-26% -$1.01K ﹤0.01% 1326
2024
Q4
$4.19K Buy
91
+86
+1,720% +$3.85K ﹤0.01% 1249
2024
Q3
$228 Buy
+5
New +$228 ﹤0.01% 1486
2023
Q2
Sell
-2
Closed -$92 1477
2023
Q1
$92 Hold
2
﹤0.01% 1400
2022
Q4
$100 Hold
2
﹤0.01% 1413
2022
Q3
$0 Hold
2
﹤0.01% 1405
2022
Q2
$0 Hold
2
﹤0.01% 1231
2022
Q1
$0 Hold
2
﹤0.01% 971
2021
Q4
$0 Hold
2
﹤0.01% 886
2021
Q3
$0 Hold
2
﹤0.01% 881
2021
Q2
$0 Hold
2
﹤0.01% 843
2021
Q1
$0 Buy
+2
New +$110 ﹤0.01% 779

Other funds holding QGEN

Hexagon Capital Partners's QGEN Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Qiagen (QGEN) in Q2 2025, closing a stake of 67 shares — an estimated $2.69K sold.

Hexagon Capital Partners first reported a position in QGEN in Q1 2021 and held it in 12 quarters. The position peaked at $4.19K in Q4 2024. 317 funds tracked by Wall St. Rank hold QGEN as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Qiagen position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 67 Qiagen shares in Q2 2025, an estimated $2.69K.
  • Hexagon Capital Partners first reported a position in Qiagen in Q1 2021 and held it in 12 quarters.
  • Hexagon Capital Partners's Qiagen position peaked at $4.19K in Q4 2024.
  • 317 funds tracked by Wall St. Rank held Qiagen as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.